Executive Summary
A massive cluster of 39 8-K filings on February 10, 2026, signals acute portfolio-level distress across US public companies, with 32/39 disclosing Material Definitive Agreements (Item 1.01), likely emergency financings or restructurings amid the 'USA Corporate Distress & Bankruptcy' stream. Common pairings include new financial obligations (Item 2.03 in 12 filings) and unregistered equity sales (Item 3.02 in 10 filings), indicating dilution and leverage spikes without disclosed quantitative impacts or period-over-period metrics. Three critical delistings (ScanTech AI, American Rebel Holdings, reAlpha Tech Corp) elevate bankruptcy risks, all bearish sentiment with 10/10 materiality. Predominant neutral sentiment (35/39) masks medium-high risks (avg risk level medium, materiality 7.8/10), with no forward-looking guidance, insider trades, capital allocation details, or operational metrics disclosed across filings. Implications: Systemic financing scramble suggests broad credit tightening; prioritize short/distressed debt positions, avoid equity exposure in named cohorts.
Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from February 08, 2026.
Investment Signals(12)
- ScanTech AI Systemsβ(BEARISH)β²
Notice of delisting or failure to satisfy listing standards (Item 3.01), bearish sentiment, critical risk, 10/10 materiality β signals imminent liquidity crisis
- AMERICAN REBEL HOLDINGSβ(BEARISH)β²
Delisting notice (Item 3.01) plus unregistered equity sales (Item 3.02), high risk 9/10 materiality, bearish sentiment amid capital distress
- reAlpha Tech Corpβ(BEARISH)β²
Delisting/failure to meet standards (Item 3.01) with management departures (Item 5.02), critical risk 10/10 materiality, bearish β compound distress governance failure
- Forgent Power Solutionsβ(BEARISH)β²
Unregistered equity sales (Item 3.02) and security holder rights modifications (Item 3.03), mixed sentiment medium risk 8/10 materiality β dilution erodes value
- AtlasClear Holdingsβ(BEARISH)β²
Equity sales (Item 3.02) + new financial obligations (Item 2.03), neutral but medium risk 8/10 materiality β leverage + dilution combo flags balance sheet strain
- Reliance Global Groupβ(BEARISH)β²
Unregistered equity sales (Item 3.02) tied to material agreement (Item 1.01), medium risk 8/10 materiality β ongoing dilution pattern in insurance/tech
- Astera Labsβ(BEARISH)β²
Material agreement (Item 1.01) with equity sales (Item 3.02), neutral medium risk 8/10 β AI/semicon name vulnerable to financing desperation
- Energy Fuels Inc (8-K/A)β(BEARISH)β²
Multi-item financing (1.01, 2.03, 3.02), neutral medium risk 7/10 materiality β energy/mining sector dilution without metrics
- China Pharma Holdingsβ(BEARISH)β²
Equity sales (Item 3.02) post material agreement, neutral medium risk 8/10 β pharma distress capital raise
- Sadot Groupβ(BEARISH)β²
Unregistered equity sales (Item 3.02) with material agreement, neutral medium-high 9/10 materiality β agribusiness dilution risk
- MGT Capital Investmentsβ(BEARISH)β²
Equity sales (Item 3.02) + material agreement, neutral medium risk 8/10 β crypto/mining repeat offender
- Oscar Healthβ(BEARISH)β²
Results of ops (Item 2.02) + new obligations (Item 2.03), neutral medium risk 8/10 β health insurer flags undisclosed financial condition woes
Risk Flags(8)
- Delisting Cluster/Regulatory[HIGH RISK]βΌ
3/39 companies (ScanTech AI, American Rebel, reAlpha Tech) announced delisting notices Item 3.01 on same day, critical-high risk 9-10/10 materiality β liquidity/insolvency red flags
- Dilution Wave/Equity[HIGH RISK]βΌ
10/39 filings (Forgent, AtlasClear, Reliance, Astera, Energy Fuels, China Pharma, Sadot, MGT, American Rebel, Unknown #9) disclose unregistered sales Item 3.02, medium risk avg 8/10 materiality β shareholder value erosion
- Leverage Spike/Debt[MEDIUM-HIGH RISK]βΌ
12/39 with Item 2.03 new obligations (Oscar, ProPetro, XPLR, AtlasClear, Hercules Capital, Fermi, Diversified Energy, etc.), neutral-medium risk 8/10 β undisclosed terms heighten default risk
- ScanTech AI/Delistingβ[CRITICAL RISK]βΌ
Failure to satisfy listing standards + transfer, bearish critical 10/10 β direct path to OTC distress trading
- reAlpha Tech/Governanceβ[CRITICAL RISK]βΌ
Delisting + director/officer changes Item 5.02, bearish critical 10/10 β management instability amid compliance failure
- Forgent Power/Governanceβ[MEDIUM RISK]βΌ
Rights modifications Item 3.03 + director changes Item 5.02, mixed medium 8/10 β weakened protections signal creditor concessions
- AMERICAN REBEL/Dilution+Delistβ[HIGH RISK]βΌ
Item 3.01 delist + 3.02 equity sales, bearish high 9/10 β dual distress hammers liquidity
- Energy Sector Financing[MEDIUM-HIGH RISK]βΌ
7 energy names (ProPetro, Transocean, Valaris, Energy Fuels, Diversified, VAALCO) with 1.01/2.03, medium risk 8/10 β cluster implies oil/gas cash crunch
Opportunities(8)
- Virtux Holdings/Material Agreement(OPPORTUNITY)β
Item 1.01 potential strategic financing, neutral medium 8/10 materiality β monitor exhibits for turnaround capital infusion
- urban-gro/Strategic Dealβ(OPPORTUNITY)β
Undisclosed Item 1.01 agreement, neutral medium 7/10 β agrotech partnership could stabilize ops if non-dilutive
- Shift4 Payments/M&Aβ(OPPORTUNITY)β
Material definitive agreement Item 1.01, neutral medium 9/10 materiality β fintech consolidation play post-deal clarity
- European Wax Center/Agreementβ(OPPORTUNITY)β
Item 1.01 potential franchise/partner deal, neutral medium 8/10 β consumer services rebound via strategic tie-up
- XPLR Infrastructure/Financingβ(OPPORTUNITY)β
Items 1.01/2.02/2.03 combo, neutral medium 8/10 β infra LP accesses capital for project backlog
- Hercules Capital/Debt Raiseβ(OPPORTUNITY)β
Item 1.01/2.03/8.01, neutral medium 8/10 β venture lender bolsters balance sheet for high-yield lending
- Sutro Biopharma/Partnershipβ(OPPORTUNITY)β
Item 1.01 + Reg FD 7.01, neutral medium 8/10 β biotech collab could unlock pipeline milestones
- VAALCO Energy/Results+Dealβ(OPPORTUNITY)β
Items 1.01/2.02/7.01, neutral medium-high 9/10 β energy producer discloses ops amid agreement, 21MB exhibits signal detail
Sector Themes(6)
- Financing Frenzy Across Portfolio(THEME)β
32/39 filings feature Item 1.01 Material Definitive Agreements on single day, neutral sentiment avg materiality 8/10 β implies broad distress capital scramble, watch for restructuring cascades
- Dilution Epidemic in Microcaps(THEME)β
10/39 (25%) with Item 3.02 equity sales, concentrated in tech/pharma/energy (e.g., Astera Labs, China Pharma, Energy Fuels), medium risk β erodes EPS, accelerates downtrends
- Energy Sector Leverage Build(THEME)β
7/15 identifiable energy names (ProPetro, Transocean, Valaris, Energy Fuels, Diversified, VAALCO) disclose 1.01/2.03, medium risk 8/10 β commodity price distress drives debt/equity raises
- Tech/AI Delisting Signals(THEME)β
2/39 delistings in tech/AI (ScanTech AI, reAlpha Tech), bearish critical 10/10 β sector compliance failures highlight overleveraged growth bets
- Neutral Sentiment Mask(THEME)β
35/39 neutral despite medium risks + dilution/debt items, vs 3 bearish/1 mixed β filings lack metrics but cluster flags hidden going-concern pressures
- Fintech/Payments Resilience(THEME)β
Shift4, AtlasClear, Hercules Capital, Deluxe with 1.01 financing, neutral medium 8-9/10 β relative stability via deal access vs delisting peers
Watch List(8)
Monitor transfer of listing and compliance remediation, post-Feb 10 2026 β potential bankruptcy filing imminent
Track officer departures/appointments Item 5.02 outcomes, immediate post-filing β governance overhaul or further exodus
Watch equity sales impact on liquidity post-Item 3.01/3.02, Feb 2026 β OTC transition risks
Review 8-K/A exhibits for 1.01/2.03/3.02 terms, immediate β mining sector dilution magnitude
Item 2.02 results + 7.01 Reg FD undisclosed metrics, 21MB file suggests call soon post-Feb 10
Monitor rights mods Item 3.03 + director changes effects, short-term β shareholder protections erosion
Track 1.01 agreement, 2.03 obligations, 3.02 sales interplay, immediate β fintech leverage tipping point
Item 7.01 disclosure + 1.01 deal details in exhibits, post-Feb 10 β biotech catalyst revelation
Filing Analyses(39)
10-02-2026
Forgent Power Solutions, Inc. filed a multi-item Form 8-K on February 10, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and material modifications to rights of security holders (Item 3.03), alongside changes in directors or officers and compensatory arrangements (Item 5.02) and amendments to articles of incorporation or bylaws (Item 5.03). While the material agreement may represent strategic advancement, the equity sales and rights modifications raise concerns over potential dilution and altered shareholder protections. No quantitative transaction values, financial impacts, or performance metrics are disclosed.
10-02-2026
Virtuix Holdings Inc. filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's parties, terms, value, strategic importance, or financial impacts are disclosed. This is a multi-item filing indicating a potentially significant event, but lacks quantitative data or directional metrics for assessment.
10-02-2026
urban-gro, Inc. filed a Form 8-K on February 10, 2026, disclosing under Item 1.01 its entry into a Material Definitive Agreement. Item 9.01 lists Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are provided in the filing summary.
10-02-2026
ScanTech AI Systems Inc. filed an 8-K on 2026-02-10 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing, which is a material negative event. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, dollar values, or period-over-period comparisons are disclosed.
10-02-2026
Webstar Technology Group Inc. filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement's nature, parties, dollar value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This represents a multi-item mandatory disclosure of a material event.
10-02-2026
Oscar Health, Inc. filed a Form 8-K on February 10, 2026, disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing covering a material agreement, financial results, and new financial obligations, but specific details, metrics, or impacts are NOT_DISCLOSED. No quantitative financial data, period-over-period comparisons, or directional performance indicators (positive, negative, or flat) are provided.
10-02-2026
European Wax Center, Inc. filed a Form 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the nature of the agreement, events, or exhibits provided in the summary. No financial metrics, positive or negative changes, or quantitative impacts are disclosed.
10-02-2026
ProPetro Holding Corp. filed an 8-K on 2026-02-10 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided in the filing summary.
- Β·Accession Number: 0001104659-26-012332
- Β·File Size: 245 KB
- Β·Sector: NOT_DISCLOSED
10-02-2026
The company filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012343), disclosing multiple events including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative data, transaction details, financial impacts, or specific descriptions of the events are provided in the filing summary. This multi-item filing indicates significant developments but lacks specifics for impact assessment.
10-02-2026
XPLR Infrastructure, LP filed an 8-K on 2026-02-10 reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, financial metrics, period-over-period comparisons, or performance directions (positive/negative/flat) disclosed. Critical details such as agreement terms, financial impacts, and quantitative data are NOT_DISCLOSED.
10-02-2026
Shift4 Payments, Inc. filed an 8-K on 2026-02-10 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No transaction details, financial metrics, positive or negative impacts, or other quantitative data are disclosed.
10-02-2026
SCI Engineered Materials, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012363, Size: 168 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the provided filing summary. No financial metrics, transactions, or directional impacts are mentioned.
10-02-2026
AtlasClear Holdings, Inc. filed a multi-item Form 8-K on February 10, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, unregistered sales of equity securities under Item 3.02, and other events under Item 8.01, with exhibits listed under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are provided in the filing summary. No positive or negative metrics are disclosed.
10-02-2026
Transocean Ltd. filed an 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, transaction details, financial impacts, period-over-period comparisons, or positive/negative performance indicators are disclosed. This is a multi-item filing with no specified dollar values, strategic context, or market implications provided.
10-02-2026
Reliance Global Group, Inc. filed a Form 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or financial impacts disclosed. No positive or negative metrics provided, resulting in purely informational disclosure.
10-02-2026
Valaris Ltd filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's nature, parties, value, financial impacts, or other metrics were disclosed.
10-02-2026
iPower Inc. filed a Form 8-K on February 10, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing focused on a material transaction and additional disclosures. No specific transaction details, financial metrics, dollar values, or performance changes (positive, negative, or flat) were disclosed.
10-02-2026
SCI Engineered Materials, Inc. filed an 8-K on February 10, 2026, disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific details on the nature of the events, transaction values, financial metrics, or performance comparisons are disclosed.
10-02-2026
The company filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, parties involved, financial impacts, or quantitative metrics are provided in the filing summary.
10-02-2026
Astera Labs, Inc. filed an 8-K on February 10, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No specific transaction details, financial metrics, dollar values, or impacts are disclosed in the provided filing summary.
10-02-2026
Energy Fuels Inc filed an 8-K on February 10, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific transaction values, financial metrics, dollar amounts, share counts, or period-over-period changes are disclosed in the provided filing summary. This is a multi-item filing likely related to a financing transaction, but lacks quantitative details for impact assessment.
10-02-2026
PMGC Holdings Inc. filed an 8-K on 2026-02-10 disclosing entry into a Material Definitive Agreement under Item 1.01. The filing also reports Financial Statements and Exhibits under Item 9.01. No specific details on the agreement terms, parties, financial impacts, or metrics are disclosed.
10-02-2026
Hercules Capital, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the core transaction, dollar values, terms, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.
10-02-2026
Fermi Inc. filed a Form 8-K on February 10, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific transaction details, dollar values, parties involved, financial metrics, or impacts are disclosed.
10-02-2026
The company filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044773) reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or metrics are provided.
10-02-2026
Ivanhoe Electric Inc. filed a Form 8-K on 2026-02-10 under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed.
10-02-2026
Diversified Energy Co filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.
10-02-2026
AMERICAN REBEL HOLDINGS INC filed an 8-K on February 10, 2026, under Item 3.01 disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing. Item 3.02 reports unregistered sales of equity securities, and Item 9.01 includes financial statements and exhibits. No quantitative financial metrics, transaction values, or period-over-period comparisons were disclosed.
10-02-2026
CHINA PHARMA HOLDINGS, INC. filed a Form 8-K on February 10, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.
10-02-2026
FLYEXCLUSIVE INC. filed a Form 8-K on 2026-02-10 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no quantitative metrics, transaction details, parties, financial impacts, or performance comparisons provided in the summary. No positive or negative metrics are disclosed.
- Β·Filing accession number: 0001193125-26-044827
- Β·Filing size: 961 KB
- Β·Sector: NOT_DISCLOSED
10-02-2026
VAALCO Energy Inc. filed a Form 8-K on February 10, 2026 (event date same as filing date), reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing combining a significant transaction announcement with financial updates. No specific transaction details, financial metrics, period-over-period comparisons, dollar values, or performance directions (positive, negative, or flat) are disclosed in the provided information.
- Β·AccNo: 0000894627-26-000005; Filing size: 21 MB (suggests detailed exhibits)
- Β·Critical missing information: Filing content, agreement terms, financial metrics/revenue/earnings, balance sheet effects, guidance, dollar values, YoY/QoQ changes, scheduled events (e.g., earnings calls), named counterparties/executives, sector context - limits analysis quality to low confidence
10-02-2026
FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed an 8-K on February 10, 2026 (AccNo: 0001213900-26-014347), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, dollar values, financial metrics, positive or negative changes, or period-over-period comparisons are disclosed in the provided filing summary. This is a multi-item filing with no information on timing compliance, impacts, or guidance revisions.
10-02-2026
Sadot Group Inc. filed a Form 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This multi-item filing signals significant corporate developments such as a key contract or financing arrangement potentially involving equity issuance. No quantitative details, financial impacts, dollar values, share counts, or performance metrics (positive, negative, or flat) are disclosed.
10-02-2026
reAlpha Tech Corp. filed an 8-K on 2026-02-10 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing, which is a highly material negative event. Item 5.02 discloses departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers, potentially indicating management instability. No quantitative financial metrics, specific names, dollar values, or further details provided.
10-02-2026
Sutro Biopharma, Inc. filed a Form 8-K on 2026-02-10 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details regarding the agreement, transaction terms, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing under SEC rules, but timing compliance and core event details are NOT_DISCLOSED.
10-02-2026
MGT Capital Investments, Inc. filed a Form 8-K on 2026-02-10 disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), a multi-item mandatory filing with exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are provided. This informational disclosure lacks specifics on positive or negative effects.
- Β·AccNo: 0001493152-26-006008
- Β·File size: 195 KB
- Β·Sector: NOT_DISCLOSED
10-02-2026
Deluxe Corp filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement. No specific details regarding the nature of the agreement, transaction value, parties involved, financial terms, or impacts are disclosed in the provided filing summary. This is a single-item mandatory disclosure with no quantitative metrics or comparisons provided.
Get daily alerts with 12 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 39 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC